Category Archives: MRK

An Update on Merck (MRK)

Product Pipeline Successes. Merck has enjoyed a couple of notable successes in its product pipeline over the past year. The first and most important is Keytruda (pembrolizumab), the company‚Äôs anti-PD-1 (programmed death receptor-1) immunotherapy treatment for cancer. Keytruda has already … Continue reading

Posted in Financial Reporting, MRK | Tagged , | Leave a comment